Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

IL-4 gene variation may increase the risk of alopecia areata in Turkish people.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Mice with extra human KLK14 had hair and skin problems, including weaker cell bonds and inflammation, linked to Netherton syndrome.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Red light at 627 nm can safely trigger IL-4 release in skin cells, potentially helping treat inflammatory skin conditions.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

CGF therapy may effectively treat psoriasis by reducing inflammation.

1,25-(OH)2D3 helps hair grow by blocking certain harmful signals.

Higher IL-17A levels indicate more severe alopecia areata.

The 18-year-old girl likely has a condition called müllerian agenesis, which caused her to not have a uterus and experience no menstrual periods.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

18β-glycyrrhetinic acid from licorice root is good for skin and hair treatments but has absorption challenges.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Cucurbitacin helps mice grow hair by blocking a protein that stops hair growth.

Oral minoxidil helps hair regrowth in 80% of alopecia patients, but only 18% see cosmetic improvement.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

COVID-19 infection may trigger alopecia areata in some patients.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Epidermal keratinocytes start wound healing and inflammation after schistosome infection.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Tsukushi helps control inflammation and aids in wound healing.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Implanting hair-follicle stem cells in mice brains helped repair brain bleeding and reduced brain inflammation.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.